RT Journal Article SR Electronic T1 Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF JF Cleveland Clinic Journal of Medicine JO Cleve Clin J Med FD Cleveland Clinic DO 10.3949/ccjm.87a.ccc057 A1 Leonard H. Calabrese A1 Tiphaine Lenfant A1 Cassandra Calabrese YR 2020 UL http://www.ccjm.org/content/early/2020/07/30/ccjm.87a.ccc057.abstract AB Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been used experimentally in patients with acute respiratory distress syndrome. Recombinant GM-CSF administered by direct inhalation is currently being studied in a cohort of patients with advanced COVID-19.